Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China
· Delayed Price · Currency is CNY 3.720
-0.030 (-0.80%)
May 30, 2025, 2:45 PM CST
Shenzhen Glory Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 22.36 | 22.28 | -148.89 | -308.06 | 44.52 | 162.14 | Upgrade
|
| Depreciation & Amortization | 102.39 | 102.39 | 95.88 | 125 | 76.68 | 55.1 | Upgrade
|
| Other Amortization | 2.5 | 2.5 | 3.51 | 3.26 | 6.57 | 3.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.12 | -0.12 | 0.03 | - | 0.03 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.2 | 3.2 | 13.94 | 73.06 | 1.23 | 8.91 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.02 | -4.02 | 3.37 | 102.94 | -28.53 | 10.05 | Upgrade
|
| Provision & Write-off of Bad Debts | 28.6 | 28.6 | 53.09 | 127.28 | 6.26 | -24.13 | Upgrade
|
| Other Operating Activities | 46.23 | 3.59 | 29.13 | 63.34 | 63.13 | 241.64 | Upgrade
|
| Change in Accounts Receivable | -144.58 | -144.58 | 29.17 | 156.27 | 49.62 | 116.21 | Upgrade
|
| Change in Inventory | 105.77 | 105.77 | 8.73 | -55.92 | -23.82 | -41 | Upgrade
|
| Change in Accounts Payable | 2.9 | 2.9 | -103.46 | -146.37 | 48.14 | -43.48 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 9.43 | Upgrade
|
| Operating Cash Flow | 163.67 | 120.95 | 17.63 | 96.45 | 242.6 | 497.54 | Upgrade
|
| Operating Cash Flow Growth | 59.36% | 585.90% | -81.72% | -60.24% | -51.24% | 255.69% | Upgrade
|
| Capital Expenditures | -86.15 | -82.15 | -42.07 | -57.3 | -429.97 | -254.21 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.26 | 2.26 | 0.19 | 11.72 | 0.39 | 0.62 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -39.2 | Upgrade
|
| Divestitures | - | - | 1.08 | 1.5 | - | -27.93 | Upgrade
|
| Investment in Securities | -2.45 | -10.94 | 114.67 | -132.77 | -141.79 | 174.85 | Upgrade
|
| Other Investing Activities | 5 | 3.85 | - | - | 7.99 | 3.27 | Upgrade
|
| Investing Cash Flow | -81.35 | -86.98 | 73.87 | -176.85 | -563.39 | -148.6 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 27.84 | 148.9 | 302.42 | Upgrade
|
| Long-Term Debt Repaid | - | -21.06 | -41.46 | -88.82 | -248.39 | -204.25 | Upgrade
|
| Net Debt Issued (Repaid) | -226.64 | -21.06 | -41.46 | -60.98 | -99.49 | 98.18 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 108.83 | - | Upgrade
|
| Common Dividends Paid | -6.55 | -11.03 | -58.85 | -163.95 | -30.29 | -49.77 | Upgrade
|
| Other Financing Activities | -62.6 | 27.73 | 21.7 | 33.84 | 29.27 | 36.51 | Upgrade
|
| Financing Cash Flow | -295.79 | -4.36 | -78.61 | -191.09 | 8.32 | 84.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | 23.1 | 17.14 | 7.15 | 6.05 | 4.73 | -20.28 | Upgrade
|
| Net Cash Flow | -190.36 | 46.74 | 20.04 | -265.44 | -307.74 | 413.57 | Upgrade
|
| Free Cash Flow | 77.51 | 38.8 | -24.44 | 39.15 | -187.38 | 243.33 | Upgrade
|
| Free Cash Flow Growth | 25.15% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.34% | 2.68% | -2.05% | 3.07% | -10.47% | 10.73% | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.04 | -0.03 | 0.05 | -0.21 | 0.29 | Upgrade
|
| Cash Income Tax Paid | - | -7 | -2.51 | -29.91 | -4.52 | -26.64 | Upgrade
|
| Levered Free Cash Flow | 20.2 | 22.97 | 58.06 | 3.61 | -109.44 | 80.2 | Upgrade
|
| Unlevered Free Cash Flow | 24.42 | 26.62 | 59.31 | 6.39 | -104.92 | 90.81 | Upgrade
|
| Change in Net Working Capital | 9.72 | 6.3 | -71.59 | -20.49 | -199.23 | -35.72 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.